US Congress Senate Bill 640 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Republican 12-3)
Status: Introduced on March 4 2019 - 25% progression, died in committee
Action: 2019-03-04 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale. Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager. Additionally, the Centers for Medicare & Medicaid Services must establish certain quality measures for PDP sponsors to use when determining incentive payments and adjustments (e.g., performance payments) to pharmacies.

Phair Pricing Act of 2019

Sen. John Kennedy [R-LA]	Sen. Shelley Capito [R-WV]	Sen. Cindy Hyde-Smith [R-MS]	Sen. Tom Cotton [R-AR]
Sen. Marsha Blackburn [R-TN]	Sen. Jon Tester [D-MT]	Sen. David Perdue [R-GA]	Sen. Kevin Cramer [R-ND]
Sen. Joe Manchin [D-WV]	Sen. John Boozman [R-AR]	Sen. Roger Wicker [R-MS]	Sen. James Lankford [R-OK]
Sen. Joni Ernst [R-IA]	Sen. Susan Collins [R-ME]	Sen. Doug Jones [D-AL]

Date	Chamber	Action
2019-03-04	Senate	Read twice and referred to the Committee on Finance.

HB1034 (Same As) 2019-02-07 - Referred to the Subcommittee on Health.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/640/all-info
Text	https://www.congress.gov/116/bills/s640/BILLS-116s640is.pdf